Caldan Therapeutics discovers novel therapeutics for metabolic diseases including Type 2 Diabetes and other indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases.
Location: United Kingdom, Scotland, City of Edinburgh
Investors 2
| Date | Name | Website |
| - | Life Arc V... | lifearcven... |
| - | Epidarex C... | epidarex.c... |
Mentions in press and media 2
| Date | Title | Description |
| 29.08.2019 | LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases | LifeArc, a UK-based medical research charity, announced today it is investing £1.5million into Caldan Therapeutics Limited, a company developing novel therapeutics for the treatment of metabolic diseases based on original work. Focusing on ... |
| 29.08.2019 | LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases | LifeArc, a UK-based medical research charity, announced today it is investing £1.5million into Caldan Therapeutics Limited, a company developing novel therapeutics for the treatment of metabolic diseases based on original work. Focusing on ... |